Category Archives: Byetta Cancer

Featured Stories
Cancer Groups Call for E-cigarettes Regulation/Research

Two Leading Cancer Groups Issue Call for Regulation of E-cigarettes and Research on Health Risks

In a joint statement, the American Society of Clinical Oncology and the American Association for Cancer Research have called on the federal government to move quickly to regulate e-cigarettes and increase research on their health effects. These leading research and treatment organizations asked the Food and Drug Administration (FDA) to make ...

Read More

Study Suggests Hormonal Contraceptives Linked to Brain Tumor

Study Suggests Hormonal Contraceptives Linked to Increased Brain Tumor Risk

A study of Danish women of reproductive age suggests that long-term use of hormonal contraceptives is associated with an increased risk of brain tumors.

Read More

Indiana Woman Alleges Serious Injuries From Transvaginal Mesh Products

Parker Waichman LLP, a national law firm, just filed a lawsuit on behalf of a woman who suffered injuries after receiving transvaginal mesh implants. The lawsuit suit alleges that the transvaginal mesh created an unreasonable risk and directly caused her injuries.

Read More

FDA Warning for Bone Graft Products in Patients Under 18

FDA Safety Warning for Bone Graft Products in Patients Under 18

FDA issued safety alerts to patients, parents & guardians, bone graft devices w/recombinant proteins or synthetic peptides not to be the first treatment for 18 & under.

Read More

Older Patients Face Heart Attack Risk Following Surgery

Older Hip Implant, Knee Replacement Patients Face Heart Attack Risk Following Surgery

An emerging report reveals that older hip implant and knee replacement patients face increased heart attack risks following surgery. The risk for acute myocardial infarction (AMI) was seen in the first two weeks after these surgical procedures.

Read More

West Virginia Man Claims Metal-on-Metal DePuy Pinnacle Hip Replacement Led to Pain, Elevated Cobalt Levels

A West Virginia man fitted with a metal-on-metal version of DePuy Orthopaedics’ Pinnacle Hip Implant System has filed suit against the company and its parent, Johnson & Johnson, alleging the device caused him to suffer pain and elevated cobalt levels. The Plaintiff is being represented by the national law ...

Read More

Birth Control Shot Depo-Provera may Increase HIV Risk

Birth Control Shot Depo-Provera may Increase HIV Risk, Study Suggests

A new study has linked the use of Depo-Provera (medroxyprogesterone acetate), an injectable type of birth control, to an increased risk of HIV infection.

Read More

Medtronic Infuse Lawsuit Alleges Off-Label Use Cause Painful Complications

A man in Louisiana has filed suit against Medtronic Inc. over injuries allegedly cause by off-label use of its Infuse Bone Graft product. The plaintiff, who received Infuse during transforaminal spinal lumbar fusion surgery, claims that the bone growth protein caused unwanted bone growth along his spine, worsening the back ...

Read More

New York City Council Calls for Zadroga Act to be Renewed

New York City Council Calls for Zadroga Act to be Renewed

New York City Council members are calling for the Zadroga Act, which provides compensation and medical treatment to 9/11 victims, to be renewed.

Read More

Study: Type 2 Diabetes Drugs May Lead to Pancreatic Damage

A recent study found that Type 2 diabetics taking drugs such as Januvia and Byetta, might be at increased risk for pancreatic damage, including pancreatic cell growth that could lead to cancer. The study, out of the University of California, … Continue reading

Posted in Byetta Cancer, Pharmaceuticals |

Some Type 2 Diabetes Drugs Associated with Pancreatitis, Pancreatic Cancer

Some Type 2 diabetes drugs are being associated with potential increased risks for pancreatitis and pancreatic cancer. The drugs, known as incretin mimetic drugs include drugs such as  Byetta and Bydureon (exenatide); Victoza (liraglutide); Januvia, Janumet, Janumet XR, and Juvisync … Continue reading

Posted in Byetta Cancer, Pharmaceuticals |

FDA Evaluating Cancer Risks in Type 2 Diabetes Drugs

In a just-released U.S. Food and Drug Administration (FDA) Drug Safety Communication, the agency said it is investigating reports of possible increased risk of pancreatitis and pre-cancerous findings in some Type 2 diabetes drugs. Incretin mimetic drugs imitate the body’s … Continue reading

Posted in Byetta Cancer, Pharmaceuticals |

JAMA Study: Januvia, Byetta Double Risks for Pancreatitis

Prior research revealed that Januvia (sitagliptin) and Byetta (exenatide), prescribed for the treatment of Type 2 diabetes, have been associated with reports of increased risks for pancreatic and thyroid cancers. Now, a new study finds that the drugs may double … Continue reading

Posted in Byetta Cancer, Pharmaceuticals |

Januvia, Byetta Linked to Adverse Health Events

Januvia (sitagliptin) and Byetta (exenatide), prescribed for the treatment of Type 2 diabetes, have been associated with reports of increased risks for pancreatic and thyroid cancers. Researchers at the University of California, Los Angeles looked at the both Januvia and … Continue reading

Posted in Byetta Cancer, Pharmaceuticals |

Amylin Hid Byetta Study Showing Association with Heart Side Effects, FDA Says

Amylin Pharmaceuticals, the maker of Byetta, is coming under fire for allegedly hiding a study that revealed serious heart risks associated with the type 2 diabetes medication.  According to a report from TheStreet.com, the U.S. Food & Drug Administration (FDA) … Continue reading

Posted in Byetta Cancer, Pharmaceuticals | Tagged |

Pancreas Worries Have Some Docs Backing Away From Byetta, Januvia

A new study indicates that some doctors are becoming wary of Januvia (sitagliptin) and Byetta (exenatide), after research linked the type 2 diabetes drugs to an increased risk of pancreatitis and pancreatic cancer. The survey, conducted by DTW Research, found … Continue reading

Posted in Byetta Cancer, Pharmaceuticals |

Victoza Raises Thyroid Tumor, Pancreatitis Fears

The maker of < "http://www.yourlawyer.com/practice_areas/defective_drugs">Victoza (liraglutide) is reminding doctors of some serious side effects that may be associated with the Type II Diabetes drug – thyroid C-cell tumors and acute pancreatitis. Novo Nordisk decided to issue a “Dear Healthcare Provider” … Continue reading

Posted in Byetta Cancer, Pharmaceuticals |

Victoza, Similar Diabetes Drugs Raise Safety Concerns

< "http://www.yourlawyer.com/practice_areas/defective_drugs">Victoza, a Type 2 Diabetes drug approved just last year, is raising concerns about pancreatitis. According to the Institute for Safe Medication Practices’ (ISMP) latest “QuarterWatch” report, Victoza has been associated with a growing number of pancreatitis cases since … Continue reading

Posted in Byetta Cancer |

Amylin Wins Temporary Restraining Order in Byetta Spat

Amylin Pharmaceuticals has scored a victory in its quest to prevent Eli Lilly from using its Byetta sales force from marketing a competing drug. < "http://www.yourlawyer.com/topics/overview/Byetta-Side-Effects-Pancreatic-Liver-Thyroid-Cancer-Lawsuit">Byetta, which is treats Type II diabetes, is marketed jointly by Eli Lilly and Amylin. … Continue reading

Posted in Byetta Cancer, Pharmaceuticals |

© 2005-2018 Parker Waichman LLP ®. All Rights Reserved.